Chronic inflammatory demyelinating polyradiculoneuropathy and severe peripheral oedema: A renal explanation

Journal of Clinical Neuroscience

Volumn 7, Issue 2, 2000, Pages 148-149

  Henderson, R D ^a   Healy, H G ^b   McCombe, P A ^b   Lander, C M ^c  

^a MAYO CLINIC   (United States)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c NONE

Author keywords

Chronic inflammatory demyelinating polyradiculoneuropathy; Focal sclerosing glomerulonephritis; Oedema

Indexed keywords

FUROSEMIDE; IMMUNOGLOBULIN; PREDNISONE;

ADULT; ARTICLE; CAPILLARY PERMEABILITY; CASE REPORT; CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; DEMYELINATING DISEASE; EDEMA; FOCAL GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEINURIA;

EID: 0033927246     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1054/jocn.1999.0170     Document Type: Article

References (7)

1. Witte A. S., Burke J. F. Membranous glomerulonephritis associated with chronic progressive demyelinating neuropathy. Neurology. 37:1987;342-345.
2. Olbricht C. J., Stark E., Helmchen U., Schulze M., Brunckhorst R., Koch K-M. Glomerulonephritis associated with inflammatory demyelinating polyradiculoneuropathy: A case report and review of the literature. Nephron. 64:1993;139-141.
3. Careless D., Rigby R., Axelsen R., Boyle R. A case of Guillain-Barré syndrome with focal segmental glomerulosclerosis. Am J Nephrol. 13:1993;160-163.
4. Hartung H. P., Reiners K., Schmidt B., Stoll G., Toyka K. V. Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Ann Neurol. 30:1991;48-53.
5. Kaysen G. A., Myers B. D., Couser W. G., Rabkin R., Felts J. M. Mechanisms and consequences of proteinuria. Lab Invest. 54:1986;479-498.
6. Ballmer-Weber B. K., Dummer R., Küng E., Burg G., Ballmer P. E. Interleukin-2 induced increase of vascular permeability without decrease of the intravascular albumin pool. Br J Ca. 71:1995;78-82.
7. Heslan J-M. J., Branellec A. I., Pilatte Y., Lang P., Lagrue G. Differentiation between vascular permeability factor and II-2 in lymphocyte supernatants from patients with minimal change nephrotic syndrome. Clin Exp Immunol. 86:1991;157-162.